Novo Nordisk to slash GLP-1 list prices by up to 50% in U.S. to cut costs for insured patients
Novo Nordisk's decision to reduce GLP-1 list prices by up to 50% in the U.S. is expected to lower out-of-pocket expenses for insured patients, potenti...
Read Full Article →